R&D channel feed

In bid to low­er ARIA-E, Eli Lil­ly tries a dif­fer­ent dos­ing reg­i­men for its Alzheimer's drug

7 months ago
Pharma

Two type 1 di­a­betes pa­tients are in­sulin-free af­ter Ele­don's im­muno­sup­pres­sant and an islet trans­plant

7 months ago

Eye­point sells $100M in shares af­ter un­veil­ing eye dis­ease da­ta for drug-de­vice as­set

7 months ago

No­var­tis takes $800M Mor­phoSys write­down mere months af­ter clos­ing ac­qui­si­tion

7 months ago
Deals
Pharma

Await­ing ex­pand­ed ap­provals, Lil­ly and J&J re­lease late-stage da­ta for Crohn's treat­ments

7 months ago
Pharma

HOPO Ther­a­peu­tics wins up to $226M BAR­DA con­tract for heavy met­al poi­son­ing re­search

7 months ago

For­mer Seagen CEO David Ep­stein to lead new biotech with VEGF bi­func­tion­al an­ti­body

7 months ago
Startups

Fog­Phar­ma re­brands as Para­bilis Med­i­cines, as CEO Math­ai Mam­men high­lights next drugs

7 months ago
Startups

Rev­o­lu­tion Med­i­cines breaks ground in chal­leng­ing pan­cre­at­ic can­cer with two RAS drugs

7 months ago

Tyra's stock dips as it gives first look in chal­lenge to J&J’s blad­der can­cer drug Balver­sa

7 months ago

Bris­tol My­ers, Ideaya tout da­ta in sol­id tu­mors with cer­tain ge­net­ic mu­ta­tions

7 months ago

Bridge­Bio shares promis­ing re­sults in tri­al of Cana­van dis­ease gene ther­a­py

7 months ago
Cell/Gene Tx

Icon's quar­ter­ly earn­ings hit by biotech and phar­ma pull­back

7 months ago
Outsourcing
Pharma

Mar­i­nus plans an­oth­er round of lay­offs, cost cuts fol­low­ing Phase 3 fail

7 months ago

Zai Lab un­veils ear­ly lung can­cer da­ta as it looks to chal­lenge Am­gen's Imdell­tra

7 months ago

CRISPR ther­a­py re­duces swelling at­tacks by 81% in In­tel­lia fol­low-up study

7 months ago
Cell/Gene Tx

GSK of­fers glimpse at RSV vac­cine in at-risk younger adults be­fore ACIP meet­ing

7 months ago
FDA+

Ex­clu­sive: Moldo­va clears first gene edit­ing study for HBV in hu­mans

7 months ago

Al­to Neu­ro­science's mid-stage tri­al miss­es pri­ma­ry end­point in de­pres­sion

7 months ago

Mer­ck pays $30M to buy ‘chameleon’ ap­proach to dead­ly brain can­cers

7 months ago
Deals

Roche says it is un­de­terred by up­com­ing biosim­i­lar threat to Vabysmo

7 months ago
Pharma

Cor­rect­ed: Sang­amo to seek ac­cel­er­at­ed ap­proval for Fab­ry gene ther­a­py, claims it won't need con­fir­ma­to­ry study

7 months ago
Cell/Gene Tx
FDA+

Be Bio rais­es $82M to fund work on B cell ther­a­py in he­mo­phil­ia B

7 months ago
Financing
Startups

Ed­i­tas piv­ots away from ex vi­vo sick­le cell ther­a­py in fa­vor of in vi­vo ap­proach

7 months ago
Cell/Gene Tx
First page Previous page 20212223242526 Next page Last page
A service from the Financial Times